Funding Rounds
Chord Therapeutics

Chord Therapeutics Series A (2020, $16M)

Chord Therapeutics

Clinical-stage biopharmaceutical company developing drugs for rare diseases.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $16.00M

Raised Date: 2020-01-01